#DNA Synthesis Market Size

[latestmarketresearchnews]

DNA Synthesis Market 2030: Brief Analysis of Top Countries Data, Growth and Drivers

The global DNA synthesis market was valued at USD 3.13 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.30% from 2024 to 2030. This growth can largely be attributed to the increasing demand for DNA synthesis driven by its applications in several fields, including molecular biology, genetic engineering, and clinical diagnostics and therapeutics. Additionally, the rising need for research in drug discovery and personalized medicine is expected to further boost market expansion during the forecast period.

The market is also seeing moderate merger and acquisition activity, driven by factors such as the desire to enhance competitive positioning within the industry and the need for consolidation in a rapidly growing market. Companies are increasingly entering into collaborations to support advancements in research and development (R&D) in diagnostics and therapeutics. For example, in April 2023, Twist Bioscience, a leader in the DNA synthesis market, announced a collaboration with Astellas Pharma to assist in antibody discovery for immunotherapies. These strategic alliances are expected to strengthen the market's growth trajectory as they enhance innovation in gene-related research.

Gather more insights about the market drivers, restrains and growth of the DNA Synthesis Market

Regional Insights:

North America DNA Synthesis Market Trends

North America held the largest market share, accounting for 39.76% of the global revenue in 2023. The region’s growth is driven by heightened public awareness about genetic disorders, along with robust medical facilities and substantial investments in research and development. The prevalence of chronic illnesses, such as cancer, diabetes, and cardiovascular diseases, further amplifies the demand for DNA synthesis as a tool for understanding and treating these conditions. Additionally, North American market players are heavily investing in gene synthesis and gene therapy research, creating a fertile environment for growth. The presence of leading DNA synthesis companies in the region, along with continuous advancements in gene editing technologies, further supports regional expansion.

U.S.

The U.S. DNA synthesis market has been experiencing significant growth, largely driven by the increasing demand for synthetic DNA and RNA sequences for various applications. These include molecular research, diagnostics, and therapeutics. The market's competitive landscape is diverse, consisting of both established players and emerging companies that are eager to secure a share of this expanding market. The U.S. market is particularly influenced by advancements in personalized medicine and genetic therapies, which heavily rely on DNA synthesis for drug development, disease prevention, and treatment personalization.

Asia Pacific DNA Synthesis Market Trends

The DNA synthesis market in the Asia Pacific region is anticipated to grow at the fastest rate, with a CAGR of 17.50% from 2024 to 2030. This growth is attributed to the increasing demand for synthetic DNA in research, diagnostics, and therapeutics, along with the rising prevalence of genetic diseases and the growing need for personalized medicine.

China

China is expected to experience the highest growth rate in the DNA synthesis market, with a projected CAGR of 21.41%. Factors contributing to this growth include the rising number of contract research organizations (CROs) and the outsourcing of drug discovery and development activities by pharmaceutical and biotech companies. Additionally, China’s focus on expanding and upgrading its gene synthesis facilities is further accelerating market growth. For example, in May 2023, GenScript expanded its oligonucleotide manufacturing facility in Jiangsu, China, to enhance its production capacity.

Japan

Japan is also expected to witness significant growth due to its aging population and emphasis on personalized medicine. As a leader in scientific research, especially in biotechnology and biopharmaceuticals, Japan has a strong focus on genetic studies and gene expression profiling, which are crucial to the DNA synthesis market. These factors are expected to further drive the demand for DNA synthesis in the region.

India

The DNA synthesis market in India is anticipated to grow rapidly due to the country’s high birth rate and the significant prevalence of genetic disorders, exacerbated by factors like consanguineous marriages and founder mutations. Government initiatives, such as the "Make in India" program and biotechnology R&D grants, are empowering domestic players and attracting foreign investments. Notably, the Department of Biotechnology (DBT) launched the UMMID initiative in 2019 to address inherited genetic diseases in newborns, further stimulating the DNA synthesis market.

Europe DNA Synthesis Market Trends

Europe represents another key region in the DNA synthesis market. This is largely due to strong government support, continuous advancements in research infrastructure, and an increasing prevalence of chronic diseases like cancer, cardiovascular conditions, and genetic disorders. The growing adoption of gene therapy is also contributing to the market's growth.

UK

The DNA synthesis market in the UK is poised for growth, driven by ongoing research and innovation in genetics and molecular studies. Government initiatives and strong healthcare infrastructure provide a conducive environment for biomedical research. For instance, in November 2023, the UK's approval of the CRISPR-based gene-editing therapy Casgevy marked a significant milestone, positioning the UK DNA synthesis market for further growth.

France

France faces a significant burden from cancer, which remains a leading cause of death in the country. The demand for DNA synthesis in France is driven by its growing role in cancer diagnostics and personalized medicine, particularly through gene expression profiling and liquid biopsies. Furthermore, cardiovascular diseases, such as atherosclerosis and heart failure, are contributing to the growing interest in oligonucleotides and genetic profiles for both diagnostic and therapeutic purposes, pushing the demand for DNA synthesis technologies.

Germany

Germany’s DNA synthesis market is expected to grow due to the country’s strong R&D focus in diagnostics and therapeutics. Germany is actively promoting biotechnology and healthcare infrastructure through initiatives like “Industrie 4.0” and providing grants for R&D. These efforts not only boost the domestic market but also attract foreign investment, further driving the DNA synthesis market in Germany.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global exosomes market size was estimated at USD 177.4 million in 2024 and is anticipated to grow at a CAGR of 28.73% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key DNA Synthesis Companies:

Thermo Fisher Scientific, Inc

Twist Bioscience

BIONEER CORPORATION

Eton Bioscience, Inc.

LGC Biosearch Technologies

IBA Lifesciences GmbH

Eurofins Scientific

Integrated DNA Technologies, Inc.

Quintara Biosciences

GenScript

Order a free sample PDF of the DNA Synthesis Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

DNA Synthesis Market Research Report 2030 By Players, Regions, Types & Applications

The global DNA synthesis market was valued at USD 3.13 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.30% from 2024 to 2030. This growth can largely be attributed to the increasing demand for DNA synthesis driven by its applications in several fields, including molecular biology, genetic engineering, and clinical diagnostics and therapeutics. Additionally, the rising need for research in drug discovery and personalized medicine is expected to further boost market expansion during the forecast period.

The market is also seeing moderate merger and acquisition activity, driven by factors such as the desire to enhance competitive positioning within the industry and the need for consolidation in a rapidly growing market. Companies are increasingly entering into collaborations to support advancements in research and development (R&D) in diagnostics and therapeutics. For example, in April 2023, Twist Bioscience, a leader in the DNA synthesis market, announced a collaboration with Astellas Pharma to assist in antibody discovery for immunotherapies. These strategic alliances are expected to strengthen the market's growth trajectory as they enhance innovation in gene-related research.

Gather more insights about the market drivers, restrains and growth of the DNA Synthesis Market

Regional Insights:

North America DNA Synthesis Market Trends

North America held the largest market share, accounting for 39.76% of the global revenue in 2023. The region’s growth is driven by heightened public awareness about genetic disorders, along with robust medical facilities and substantial investments in research and development. The prevalence of chronic illnesses, such as cancer, diabetes, and cardiovascular diseases, further amplifies the demand for DNA synthesis as a tool for understanding and treating these conditions. Additionally, North American market players are heavily investing in gene synthesis and gene therapy research, creating a fertile environment for growth. The presence of leading DNA synthesis companies in the region, along with continuous advancements in gene editing technologies, further supports regional expansion.

U.S.

The U.S. DNA synthesis market has been experiencing significant growth, largely driven by the increasing demand for synthetic DNA and RNA sequences for various applications. These include molecular research, diagnostics, and therapeutics. The market's competitive landscape is diverse, consisting of both established players and emerging companies that are eager to secure a share of this expanding market. The U.S. market is particularly influenced by advancements in personalized medicine and genetic therapies, which heavily rely on DNA synthesis for drug development, disease prevention, and treatment personalization.

Asia Pacific DNA Synthesis Market Trends

The DNA synthesis market in the Asia Pacific region is anticipated to grow at the fastest rate, with a CAGR of 17.50% from 2024 to 2030. This growth is attributed to the increasing demand for synthetic DNA in research, diagnostics, and therapeutics, along with the rising prevalence of genetic diseases and the growing need for personalized medicine.

China

China is expected to experience the highest growth rate in the DNA synthesis market, with a projected CAGR of 21.41%. Factors contributing to this growth include the rising number of contract research organizations (CROs) and the outsourcing of drug discovery and development activities by pharmaceutical and biotech companies. Additionally, China’s focus on expanding and upgrading its gene synthesis facilities is further accelerating market growth. For example, in May 2023, GenScript expanded its oligonucleotide manufacturing facility in Jiangsu, China, to enhance its production capacity.

Japan

Japan is also expected to witness significant growth due to its aging population and emphasis on personalized medicine. As a leader in scientific research, especially in biotechnology and biopharmaceuticals, Japan has a strong focus on genetic studies and gene expression profiling, which are crucial to the DNA synthesis market. These factors are expected to further drive the demand for DNA synthesis in the region.

India

The DNA synthesis market in India is anticipated to grow rapidly due to the country’s high birth rate and the significant prevalence of genetic disorders, exacerbated by factors like consanguineous marriages and founder mutations. Government initiatives, such as the "Make in India" program and biotechnology R&D grants, are empowering domestic players and attracting foreign investments. Notably, the Department of Biotechnology (DBT) launched the UMMID initiative in 2019 to address inherited genetic diseases in newborns, further stimulating the DNA synthesis market.

Europe DNA Synthesis Market Trends

Europe represents another key region in the DNA synthesis market. This is largely due to strong government support, continuous advancements in research infrastructure, and an increasing prevalence of chronic diseases like cancer, cardiovascular conditions, and genetic disorders. The growing adoption of gene therapy is also contributing to the market's growth.

UK

The DNA synthesis market in the UK is poised for growth, driven by ongoing research and innovation in genetics and molecular studies. Government initiatives and strong healthcare infrastructure provide a conducive environment for biomedical research. For instance, in November 2023, the UK's approval of the CRISPR-based gene-editing therapy Casgevy marked a significant milestone, positioning the UK DNA synthesis market for further growth.

France

France faces a significant burden from cancer, which remains a leading cause of death in the country. The demand for DNA synthesis in France is driven by its growing role in cancer diagnostics and personalized medicine, particularly through gene expression profiling and liquid biopsies. Furthermore, cardiovascular diseases, such as atherosclerosis and heart failure, are contributing to the growing interest in oligonucleotides and genetic profiles for both diagnostic and therapeutic purposes, pushing the demand for DNA synthesis technologies.

Germany

Germany’s DNA synthesis market is expected to grow due to the country’s strong R&D focus in diagnostics and therapeutics. Germany is actively promoting biotechnology and healthcare infrastructure through initiatives like “Industrie 4.0” and providing grants for R&D. These efforts not only boost the domestic market but also attract foreign investment, further driving the DNA synthesis market in Germany.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global exosomes market size was estimated at USD 177.4 million in 2024 and is anticipated to grow at a CAGR of 28.73% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key DNA Synthesis Companies:

Thermo Fisher Scientific, Inc

Twist Bioscience

BIONEER CORPORATION

Eton Bioscience, Inc.

LGC Biosearch Technologies

IBA Lifesciences GmbH

Eurofins Scientific

Integrated DNA Technologies, Inc.

Quintara Biosciences

GenScript

Order a free sample PDF of the DNA Synthesis Market Intelligence Study, published by Grand View Research.

[marketresearchreportinsight]

DNA Synthesis Market Forecast Report 2030 by Size, Revenue, Business Growth and Demand

The global DNA synthesis market was valued at USD 3.13 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.30% from 2024 to 2030. This growth can largely be attributed to the increasing demand for DNA synthesis driven by its applications in several fields, including molecular biology, genetic engineering, and clinical diagnostics and therapeutics. Additionally,…

[soumyafwr]

https://carbonfacesocial.org/blogs/48912/DNA-Synthesis-Market-Overview-Size-Share-and-Forecast-2031

DNA Synthesis Market Overview, Size, Share and Forecast 2031

[neha24blog]

DNA Synthesis Market Segmented On The Basis Of Service Type, Application, End-Use, Region And Forecast To 2030: Grand View Research Inc.

San Francisco, 4 July 2023: The Report DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research And Development, Therapeutics), By End-use, By Region, And Segment Forecasts, 2023 – 2030 The global DNA synthesis market size is expected to reach USD 12.76 billion by 2030, according to a new report by Grand View…

[aartichede08]

Proteomics Market Size Estimation, Consumption, And Growth Opportunities Till 2028

Proteomics Market research report provides comprehensive information on the market. It also includes in-depth information about Market #Drivers, Opportunities, Market Restraints, Market Growth #Challenges and Cumulative #Growth Analysis. Moreover, the report also provides an in-depth analysis of the Proteomics Market by identifying key players. The report also examines the #competitive landscape of the Proteomics Market industry and analyses its impact on the growth of this market over the next few years. The segmental analysis focuses on revenue and forecast for the period 2019-2029.

Request PDF Sample Copy of Report @ https://www.axiommrc.com/request-for-sample/11462-proteomics-market-report

Proteomics refers to the large scale characterization of the entire protein complement of cells, tissues and even whole organisms. Proteomics is the large-scale study of proteins. Proteins are vital parts of living organisms, with many functions such as the formation of structural fibers of muscle tissue, enzymatic digestion of food, or synthesis and replication of DNA.

The competitive landscape analysis of the Proteomics market is primarily focused on expanding the growth of the Proteomics market with new return type innovation, business expansion, and the increasing presence of a range of manufacturers operating in the reverse logistics market has led to growing demand for the market. 

Market Key Players

Bio-Rad Laboratories, Inc.

Illumina, Inc.

Agilent Technologies, Inc.

Danaher Corporation

General Electric

Thermo Fisher Scientific, Inc.

Bruker Corporation

F. Hoffmann-La Roche Ltd.

Promega Corp.

Merck KGaA

Biognosys AG

Bruker

Caprion Biosciences Inc.

Luminex Corporation

Genzyme Corporation

LI-COR, Inc.

Waters Corporation

To Buy Proteomics Market Report https://www.axiommrc.com/buy_now/11462-proteomics-market-report

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Blog: https://industrywatch24.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

Instagram: https://www.instagram.com/axiom_mrc

Facebook: https://www.facebook.com/axiommrc

[globalinsightsservices]

DNA Data Storage Solutions market focuses on technologies and services for encoding, storing, and retrieving digital information using synthetic DNA.

Market Definition

The. DNA Data Storage Solutions market focuses on technologies and services for encoding, storing, and retrieving digital information using synthetic DNA. By harnessing DNA's exceptional storage density and durability, this approach offers a sustainable alternative to traditional methods. The market encompasses DNA synthesis, sequencing, and bioinformatics services, meeting the rising demand for efficient data management across industries such as healthcare, finance, and IT, while paving the way for advancements in data preservation and accessibility.

Market SegmentationTypeIn-vitro DNA Synthesis, In-vivo DNA SynthesisProductDNA Storage Drives, DNA Synthesis Kits, DNA Sequencing Kits, DNA Storage SoftwareServicesData Encoding, Data Decoding, Data Retrieval, Consulting Services, Maintenance ServicesTechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Microarray, CRISPR, Synthetic BiologyComponentDNA Strands, Enzymes, Nucleotides, DNA Synthesizers, DNA SequencersApplicationData Archiving, Data Backup, Data Retrieval, Data Security, BioinformaticsFormLiquid DNA, Solid DNA, Encapsulated DNAMaterial TypeSynthetic DNA, Natural DNA, Hybrid DNAEnd UserBiotechnology Companies, Pharmaceutical Companies, Academic & Research Institutes, IT & Data Centers, Government OrganizationsProcessDNA Synthesis, DNA Sequencing, Data Encoding, Data Decoding

Request Sample: https://www.globalinsightservices.com/request-sample/?id=GIS32614

Research Objectives

Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region

Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling

Identify factors influencing market growth and challenges, opportunities, drivers and restraints

Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates

Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities

Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market

To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.

Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives

Market Outlook

The DNA data storage market is projected to grow from $1.5 billion in 2023 to $14.0 billion by 2033, achieving a CAGR of 25.0%, underscoring its strong growth potential. In 2023, the market's storage volume was estimated at 120 petabytes, with projections to reach 500 petabytes by 2033. The archival storage segment leads with a 45% market share, followed by cold storage at 30% and active storage at 25%. The dominance of the archival segment is attributed to the rising demand for long-term data preservation and DNA storage's superior density.

Key players, including Microsoft, Twist Bioscience, and Illumina, hold significant market shares and drive innovation to address growing demand. The competitive landscape is shaped by advancements in DNA synthesis and sequencing, with regulatory factors such as data privacy laws and sustainability mandates influencing market strategies. The market is anticipated to grow at an annual rate of 15%, driven by technological progress and declining DNA storage costs.

While challenges include regulatory compliance and technical hurdles, the integration of AI and machine learning into data retrieval processes is expected to create new opportunities and enhance efficiencies, supporting further market expansion.

Major Players

Twist Bioscience

Catalog Technologies

DNA Script

Evonetix

Helixworks

Iridia

Molecular Assemblies

Genomes.io

Ginkgo Bioworks

Ansa Biotechnologies

Nucleic Acid Memory

Cambridge Consultants

Roswell Biotechnologies

DNA Cloud

Xenon Pharmaceuticals

Base4 Innovation

Nuclera Nucleics

Synthomics

Genomatica

Recent advancements

Recent advancements in the DNA data storage market are driving significant changes in market dynamics, including share, size, and pricing. Technological innovations are reducing costs, making DNA storage solutions more accessible. The adoption of CRISPR technology is enhancing data encoding processes, boosting efficiency and reliability. With data generation surging, DNA storage is gaining traction as a sustainable alternative to conventional methods, particularly in sectors like healthcare and finance that require secure, long-term solutions.

Regulatory frameworks are evolving to address data security and privacy, influencing market strategies and entry requirements. For instance, the European Union's strict data protection laws are shaping operational and compliance costs. Collaborations between technology and biotech firms are fostering innovation, with joint efforts focused on scalability and integration with existing IT systems.

Key market trends include the miniaturization of storage devices and the development of hybrid systems that merge DNA and traditional storage technologies, improving data retrieval speed and reliability. Sustainability is also a growing focus, as DNA storage offers a significantly lower carbon footprint compared to traditional data centers. With the exponential growth of data storage needs, the market is positioned for rapid expansion and transformation.

Request Discounted Pricing@  https://www.globalinsightservices.com/request-special-pricing/GIS32614

Research Scope

Scope - Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing - Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics - Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework - Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape - Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles - Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis

Buy your copy here:  https://www.globalinsightservices.com/checkout/single_user/GIS32614/

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Us:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[surbhijamdade]

Revenue Forecast and Competitive Landscape for the Oligonucleotide Synthesis Market

The Oligonucleotide Synthesis Market Report for 2024 provides a comprehensive overview of the Oligonucleotide Synthesis Market industry, presenting crucial data and insights into market dynamics, including growth drivers, challenges, and future potential. The report evaluates the Oligonucleotide Synthesis Market Components, focusing on significant opportunities and trends that could shape the industry's trajectory.

According to Straits Research, the global Oligonucleotide Synthesis Market market size was valued at USD 7.74 billion in 2023. It is projected to reach from USD 8.84 billion in 2024 to USD 25.57 billion by 2032, growing at a CAGR of 14.2% during the forecast period (2024–2032).

Get a Sample PDF/Excel of report starting from USD 995 :https://straitsresearch.com/report/oligonucleotide-synthesis-market/request-sample

Top Key Players of Oligonucleotide Synthesis Market :

Agilent Technologies, Inc.

ATDBio Ltd.

TriLink BioTechnologies LLC

Thermo Fisher Scientific

Nitto Denko Corporation

Merck KGaA

LGC Biosearch Technologies

Integrated DNA Technologies, Inc.

GenScript

GE Healthcare

Eurogentec

Eurofins

and more....

Key Insights from the Oligonucleotide Synthesis Market Report

Market Size Overview: The report provides comprehensive estimates of the Oligonucleotide Synthesis Marketsize, including value and sales volume, for the period.

Market Trends and Dynamics: An analysis of the key drivers, opportunities, challenges, and risks shaping the Oligonucleotide Synthesis Market.

Global Economic and Regional Impact: Evaluation of the effects of global inflation and the Russia-Ukraine conflict on the Oligonucleotide Synthesis Market.

Trade Flow Analysis: Detailed examination of import and export volumes of Oligonucleotide Synthesis Marketacross major regions.

Industry Value Chain: Insight into the Oligonucleotide Synthesis Marketvalue chain, covering raw materials, suppliers, manufacturing processes, distributors, and downstream customers.

Industry News, Policies, and Regulations: Coverage of the latest developments, policies, and regulations impacting the Oligonucleotide Synthesis Market.

Regional Analysis for Oligonucleotide Synthesis Market:

The regional analysis section of the report offers a thorough examination of the global Oligonucleotide Synthesis Market market, detailing the sales growth of various regional and country-level markets. It includes precise volume analysis by country and market size analysis by region for both past and future periods. The report provides an in-depth evaluation of the growth trends and other factors impacting the Oligonucleotide Synthesis Market market in key countries, such as the United States, Canada, Mexico, Germany, France, the United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil, and Saudi Arabia. Moreover, it explores the progress of significant regional markets, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Oligonucleotide Synthesis Market Segmentations:

By Product Type

Synthesized Oligonucleotide Product

Reagents

Equipment

By Applications

Research

PCR

Sequencing

Gene Synthesis

Diagnostics

Therapeutics

RNAi

Nucleic Acid Aptamers

Others

By End-User

Academic Research Institutes

Pharmaceutical and Biotechnology Companies

Diagnostic Laboratories

Others

Get Detail Market Segmentation :https://straitsresearch.com/report/oligonucleotide-synthesis-market/segmentation

Unit Economics must be known by C-suite professionals:

Cost of Goods Sold (COGS): Includes material, labor, and overhead costs in manufacturing.

R&D Costs: Investment in innovation and compliance with regulations.

Engineering and Design Costs: Resources for design, prototyping, and meeting technical standards.

Production Costs: Specialized manufacturing and quality control expenses.

Supply Chain Costs: Managing procurement and logistics for specialized components.

Testing and Quality Assurance: Costs for ensuring product safety and reliability.

SG&A Costs: Marketing, sales, and administrative expenses.

Revenue per Unit: Income from contracts, services, and licensing.

Gross Margin: Revenue minus COGS, showing unit profitability.

Break-even Analysis: Units or contracts needed to cover total costs.

Customer Acquisition Cost (CAC): Costs to secure new contracts.

Lifetime Value (LTV): Total revenue from a customer over time.

Capital Expenditure (CapEx): Investments in facilities and technology.

Economies of Scale: Cost reductions in larger production runs.

Profit Margin: Final profit after all expenses.

Top Reasons to Choose This Report

Access to Comprehensive Insights: Gain access to extensive analysis, research, and data that are often challenging to gather independently. This report provides valuable information, saving you significant time and effort.

Support for Informed Decisions: Enhance your decision-making process with in-depth insights into market trends, consumer behavior, and key industry factors. This report is essential for strategic planning, including investments, product development, and marketing strategies.

Gain a Competitive Edge: Stay competitive by understanding market dynamics and competitor strategies. The report provides detailed insights into competitor performance and market trends, helping you craft effective business strategies.

Cost-Effective Research Solution: Save on research costs by investing in this report, which offers a detailed and comprehensive analysis of the market. This cost-effective option eliminates the need for extensive independent research.

COVID-19 Aftermath and Geopolitical Influences: Russia-Ukraine Conflict and Middle East Crisis

The report explores the multifaceted impact of COVID-19 on the Oligonucleotide Synthesis Market market, covering both direct and indirect effects across global and local levels. It discusses market size, trends, and growth trajectories in the Oligonucleotide Synthesis Market , classified by type, application, and customer sector. Additionally, it provides a detailed evaluation of market development components before and after the pandemic, supported by a PESTEL analysis to assess key influencers and barriers to market entry. We offer the flexibility to customize the report based on specific regions, applications, or any other statistical details. Our goal is to align our analysis with your specific needs, ensuring a more complete market study. The final report will also examine the impact of the Russia-Ukraine War on the Oligonucleotide Synthesis Market market, assessing how these geopolitical events are influencing current market conditions and future opportunities.

This Report is available for purchase on :https://straitsresearch.com/buy-now/oligonucleotide-synthesis-market

About Us:

Straits Research is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.

Contact Us: email: sales@straitsresearch.com Address: 825 3rd Avenue, New York, NY, USA, 10022 Tel: +1 646 905 0080 (U.S.) +91 8087085354 (India) +44 203 695 0070 (U.K.)

[credenceresearchdotblog]

The Specialty Enzymes Market is projected to grow from USD 6,142.34 million in 2023 to an estimated USD 10,644.70 million by 2032, at a compound annual growth rate (CAGR) of 6.30% from 2024 to 2032. The specialty enzymes market has emerged as a rapidly expanding segment in the biotechnology industry, driven by growing demand in various sectors such as pharmaceuticals, food & beverages, diagnostics, and biotechnology research. These enzymes, which are customized for specific industrial applications, offer precision, efficiency, and enhanced specificity compared to traditional enzymes, making them indispensable in both industrial and clinical settings. The market is projected to grow significantly in the coming years, owing to the increasing need for innovative and efficient solutions in complex biotechnological processes.

Browse the full report at https://www.credenceresearch.com/report/specialty-enzymes-market

Market Overview

Specialty enzymes are proteins that catalyze chemical reactions in living organisms, and their role in industrial applications has evolved significantly. Unlike bulk enzymes, which are used in high quantities for processes like detergent manufacturing or biofuel production, specialty enzymes are produced and used in smaller amounts but are designed for more specialized, high-value applications. They are tailored to perform specific functions, which are often critical in processes such as disease diagnosis, drug formulation, or food processing.

The global specialty enzymes market is anticipated to grow at a compound annual growth rate (CAGR) of over 7% between 2024 and 2030, reaching a market size of more than $8 billion by the end of this period. This growth is attributed to advancements in enzyme engineering, a rise in the use of enzymes in pharmaceutical and biotechnology sectors, and an increased awareness of sustainable and eco-friendly industrial processes.

Key Market Drivers

1. Rising Demand in Pharmaceuticals and Diagnostics: One of the primary drivers of the specialty enzymes market is the increasing use of these enzymes in pharmaceutical applications, especially in drug development and production. Enzymes like proteases, lipases, and polymerases are widely used in the synthesis of therapeutic proteins, antibiotics, and other pharmaceutical products. Additionally, specialty enzymes are critical components in diagnostic kits and molecular diagnostics, including COVID-19 testing, where enzymes like reverse transcriptase play a key role.

2. Innovation in Biotechnology: The rapid progress in enzyme technology, such as protein engineering and recombinant DNA technology, has led to the development of highly specific and efficient specialty enzymes. These innovations have significantly improved the production processes in industries like biofuels, agriculture, and food processing. For example, in the food and beverage industry, specialty enzymes are used to improve product quality, enhance flavors, and extend shelf life, all while reducing environmental impact.

3. Increased Demand for Sustainable Solutions: As industries worldwide focus on reducing their environmental footprint, the demand for green and sustainable processes has risen sharply. Specialty enzymes offer eco-friendly alternatives to chemical catalysts, reducing the use of harsh chemicals and energy in industrial processes. In the textile industry, for instance, enzymes are used for fabric softening, bleaching, and desizing, eliminating the need for toxic chemicals and saving water.

4. Growing Research and Development in Biocatalysis: Biocatalysis, the process of using natural catalysts such as enzymes to perform chemical transformations, is gaining momentum in pharmaceutical and chemical industries. Specialty enzymes serve as biocatalysts in producing enantiomerically pure compounds, which are essential in the development of active pharmaceutical ingredients (APIs). This trend is further supported by the increasing investment in research and development (R&D) activities by biotech companies, aimed at discovering new enzymes with enhanced functionalities.

Challenges Facing the Market

Despite its promising growth, the specialty enzymes market faces several challenges. One major hurdle is the high cost of enzyme production and purification, which limits their use in certain applications. The complex nature of enzyme engineering and the need for specific conditions (such as temperature and pH) for optimal enzyme activity can also pose difficulties. Additionally, regulatory challenges and patent issues could slow down the introduction of new enzyme products to the market.

Key Players and Competitive Landscape

The specialty enzymes market is highly competitive, with several prominent companies driving innovation and market growth. Key players include Novozymes, DuPont, BASF, DSM, and Roche, among others. These companies are investing heavily in R&D, mergers, acquisitions, and strategic collaborations to expand their product portfolios and maintain a competitive edge. Startups and smaller firms are also entering the market, offering innovative solutions to niche problems in industries like agriculture and bioenergy.

Future Outlook

The future of the specialty enzymes market looks bright, with continuous advancements in biotechnology and increased awareness of the benefits of enzyme-based solutions. As the demand for personalized medicine grows, especially in the pharmaceutical industry, specialty enzymes will play an even more significant role in developing targeted therapies. Furthermore, the growing trend towards sustainability in industries like food and beverages, textiles, and bioenergy will provide additional growth opportunities for this market.

Key players

Brain Biotech AG

Novozymes A/S

Codexis Inc.

Sanofi

Merck KGaA

Dyadic International Inc.

Advanced Enzyme Technologies

Amano Enzyme Inc.

Hoffmann-La Roche Ltd.

New England Biolabs

BBI Solutions

Creative Enzymes

Biostatical

Sekisui Diagnostics

Segments

Based on type

Carbohydrase

Amylases

Cellulases

Others

Proteases

Lipases

Polymerases & Nucleases

Others

Based on application

Pharmaceuticals

Research & Biotechnology

Diagnostics ,

Biocatalysts

Others

 Based on form

Liquid

Dry

Based on source

Microorganisms

Plants

Animals

Based on region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/specialty-enzymes-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[rakshasns]

Vitamins & Minerals Market Trends and Share | 2023 - 2030

Vitamins & Minerals to Reach USD 29.45 Billion by 2030, Growing at a CAGR of 6.9%

Global Vitamins & Minerals Size, Share, and Forecast Report 2023-2030

Introduction

As health and wellness trends gain momentum, the Vitamins and minerals Market Size continues to experience significant growth. Valued at USD 10.17 billion in 2022, the is projected to grow at a compound annual growth rate (CAGR) of 6.9%, reaching USD 29.45 billion by 2030. With the increasing focus on preventive healthcare, rising awareness of nutrition, and expanding demand for dietary supplements, vitamins and minerals are becoming essential components in consumers' daily lives.

This press release highlights key drivers, trends, segmentation, and regional insights, alongside a forecast of the vitamins and minerals 's growth through 2030.

 Drivers and Growth Factors

Several factors are contributing to the substantial growth of the global vitamins and minerals :

Rising Health Consciousness and Preventive Healthcare: Consumers are increasingly adopting preventive healthcare practices to reduce the risk of chronic diseases. As part of this shift, vitamins and minerals are being incorporated into daily diets to address nutritional gaps and support overall well-being.

Growing Awareness of Micronutrient Deficiencies: Nutrient deficiencies, particularly those related to vitamins and minerals, have become a global health concern. Awareness campaigns and public health initiatives are educating consumers about the importance of essential micronutrients like vitamin D, vitamin C, iron, and calcium.

Aging Population and Increased Demand for Nutritional Support: The global aging population is driving demand for vitamins and minerals that support bone health, cognitive function, and cardiovascular wellness. Older adults are particularly interested in supplements that can help manage age-related health conditions.

Rise in Nutraceuticals and Functional Foods: The growing trend of functional foods, which are fortified with essential vitamins and minerals, is significantly boosting the . Nutraceuticals that target specific health benefits—such as immunity, energy, and skin health—are gaining popularity.

Expansion in Sports Nutrition and Fitness Industries: As more individuals focus on fitness and active lifestyles, there is increased demand for vitamins and minerals to support athletic performance, recovery, and muscle health. Multivitamins, magnesium, calcium, and vitamin B complexes are particularly sought after in this sector.

 Segmentation

The global vitamins and minerals can be segmented by type, application, end-user, distribution channel, form, and region.

By Type:

Vitamin A: Essential for vision, immune function, and skin health, vitamin A supplements are widely used to address deficiencies.

Vitamin B (B-complex): Vitamins B6, B12, and folate are in high demand due to their role in energy production, nerve function, and red blood cell formation.

Vitamin C: Known for its immune-boosting properties, vitamin C is one of the most consumed supplements globally.

Vitamin D: Vitamin D supports bone health, immunity, and mood regulation, making it highly sought after, particularly in regions with limited sun exposure.

Multivitamins: Multivitamin supplements are the most popular, offering a comprehensive mix of vitamins and minerals to cover a range of nutritional needs.

Calcium: Calcium is essential for bone and dental health, and supplements are frequently used to prevent osteoporosis and other bone-related conditions.

Iron: Iron supplements are widely consumed, particularly by women and individuals with anemia or other iron deficiencies.

Magnesium: Magnesium supports muscle function, energy production, and mental health. It is a key supplement in the fitness and wellness industries.

Zinc: Zinc is critical for immune function, wound healing, and DNA synthesis, making it a staple in dietary supplements, especially during cold and flu seasons.

By Application:

Food & Beverage: The demand for fortified foods and beverages is increasing as consumers seek to meet their daily nutritional requirements through functional food products.

Supplements: Dietary supplements dominate the as consumers seek convenient and efficient ways to enhance their vitamin and mineral intake.

Pharmaceuticals: Vitamins and minerals play a vital role in pharmaceutical applications, particularly in products designed to manage deficiencies and support overall health.

Animal Feed: The growing focus on animal nutrition has led to increased use of vitamins and minerals in livestock and pet feed to improve growth, immunity, and reproductive health.

Others: Other applications include personal care products and fortified infant formula.

By End-User:

Adults: Adults represent the largest consumer base for vitamins and minerals, driven by the need for energy, immunity, and overall well-being.

Geriatric: Older adults are a key demographic, particularly for supplements that support bone health, cognitive function, and cardiovascular wellness.

Pregnant Women: Prenatal vitamins and minerals, such as folic acid, calcium, and iron, are essential for supporting maternal health and fetal development.

Children: Pediatric vitamins, particularly chewable multivitamins and vitamin D, are increasingly popular as parents prioritize their children's nutritional health.

Infants: The infant segment sees strong demand for vitamins and minerals through fortified formula and specialized supplements designed for early development.

By Distribution Channel:

Pharmacies and Drug Stores: Pharmacies remain a primary distribution channel for vitamins and minerals due to the availability of professional guidance and trusted brands.

Supers and Hypers: The convenience of purchasing vitamins and minerals during routine grocery shopping has contributed to the growing presence of these products in supers and hypers.

Online Channels: E-commerce is experiencing significant growth, offering consumers access to a wider range of products, subscription services, and the convenience of home delivery.

By Form:

Capsule: Capsules are a popular form of vitamins and minerals due to their ease of consumption and precise dosage.

Tablet: Tablets remain the most widely consumed form, offering a cost-effective and stable way to deliver vitamins and minerals.

Powder: Powdered vitamins and minerals are commonly used in sports nutrition and can be easily mixed with water or other beverages.

Liquid/Gel: Liquid and gel forms are growing in popularity, particularly for those who have difficulty swallowing pills or prefer faster absorption.

Regional Outlook

North America: North America holds the largest share of the global vitamins and minerals , driven by high levels of health consciousness, an aging population, and the widespread adoption of dietary supplements. The U.S. leads the in this region, with strong demand for multivitamins, vitamin D, and calcium supplements.

Europe: Europe is the second-largest , with increasing consumer awareness about preventive healthcare. Countries like Germany, France, and the U.K. are seeing rising demand for vitamin and mineral supplements, particularly those supporting immunity and aging.

Asia-Pacific: The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Rapid urbanization, rising disposable incomes, and growing health awareness in countries such as China, Japan, and India are driving the for vitamins and minerals.

Latin America and Middle East & Africa: These regions are emerging s for vitamins and minerals, with increasing awareness of micronutrient deficiencies and improving access to dietary supplements. Brazil and South Africa are key growth areas.

Trends Shaping the Future of the Vitamins & Minerals

Personalized Nutrition: Advances in biotechnology and data analytics are enabling the development of personalized vitamin and mineral supplements based on individual health needs, genetics, and lifestyle.

Plant-Based and Vegan Supplements: The rising popularity of plant-based diets is driving demand for vegan-friendly vitamins and minerals, such as plant-based calcium and iron sources.

Clean Label and Natural Ingredients: Consumers are increasingly seeking vitamins and minerals made from natural, organic ingredients, free from synthetic additives and preservatives.

Innovation in Delivery Formats: Companies are developing innovative delivery methods, such as fast-dissolving tablets, liquid gels, and gummy vitamins, to meet diverse consumer preferences.

Key Players

Several key players are driving growth in the vitamins and minerals , including:

Bayer AG

Amway

Pfizer Inc.

Abbott Laboratories

Nature’s Bounty Co.

These companies are expanding their product portfolios, enhancing product quality, and adopting innovative technologies to meet growing global demand.

Conclusion

The global vitamins and minerals is poised for robust growth over the coming decade, driven by rising health awareness, expanding aging populations, and the increasing adoption of preventive healthcare. With a projected CAGR of 6.9% from 2023 to 2030, the is expected to reach USD 29.45 billion by 2030, offering significant opportunities for innovation and expansion across various industries.

Read More Details @ https://www.snsinsider.com/reports/vitamins-and-minerals-market-1352

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

SNS Insider Offering/ Consulting Services:

Go To Market Assessment Service

Total Addressable Market (TAM) Assessment

Competitive Benchmarking and Market Share Gain

[tamanna31]

mRNA Synthesis Raw Materials Market Size, Share, Growth, Analysis Forecast to 2030

mRNA Synthesis Raw Materials Industry Overview

The global mRNA synthesis raw materials market size was estimated at USD 1.72 billion in 2023 and is anticipated to grow at a CAGR of 2.85% from 2024 to 2030.

mRNA is synthesized by the process of transcription in the nucleus by using a template made up of a DNA nucleotide sequence. It includes various steps such as initiation, elongation, editing, and termination. mRNA synthesis has a broad range of applications in drug discovery, vaccine development, and the manufacturing of therapeutics. RNA-based vaccines have better immunogenicity, higher efficiency, and require short production time. The key factors driving the market growth include the growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research.

Gather more insights about the market drivers, restrains and growth of the mRNA Synthesis Raw Materials Market

The COVID-19 pandemic created new opportunities for mRNA technology platforms with the introduction and widespread use of vaccines. Government agencies from several nations, research institutions, and numerous biotech and pharmaceutical companies are focusing on efficient and quick methods for the rapid detection of COVID-19. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA-based COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe.

The National Institute of Allergy & Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. It shows 94.1% efficacy in symptomatic prevention from COVID-19 and in December 2020, received emergency use authorization from the US Food & Drug Administration (US FDA) for widespread immunization of people. As a result, the usage of mRNA vaccines increased exponentially during the COVID-19 pandemic.

Recently, RNA centers have been established at numerous institutions to promote therapeutic uses of RNA, particularly in vitro transcribed (IVT) mRNA. These facilities include the Yale Center for RNA Science and Medicine, the RNA Institute at the University of Albany, the State University of New York, and the RNA Therapeutic Institute at the University of Massachusetts in the United States. Additionally, university spin-off businesses funded by significant venture capital infusions such as Argos Medicines, Factor Bioscience, CureVac, Ethris, BioNTech, Moderna, eTheRNA, and Onkaido have advanced the preclinical and clinical development of mRNA-based therapeutics. Hence, growing academic and industrial interest in mRNA technology is anticipated to increase the need for mRNA synthesis raw materials, thereby boosting market growth.

Furthermore, the simplicity to manufacture the mRNA vaccine is a key reason for the development of these vaccines. For instance, it is essential for DNA to enter the nucleus, and then it can be transcribed into mRNA. However, mRNA does not need to enter the nucleus to function as it initiates protein translation in the cytoplasm. Hence, this process makes the mRNA vaccine more efficient and simple to manufacture. In contrast to viral vectors and DNA, mRNAs do not insert into the genome but express the encoded protein instantaneously. Typical cellular processes can eliminate the mRNA since it doesn’t integrate into the host genome, thus eliminating any chance of infection or insertion mutation. In addition, the In Vitro Transcription (IVT) process readily synthesizes mRNA. The process is relatively inexpensive and can be quickly applied to a variety of therapies. Such advantages of mRNA vaccines are anticipated to drive the market during the study period.

Moreover, several operating players in the market and various research institutes are receiving funding for the development of novel mRNA therapeutics. For instance, in October 2022, the University of Columbia received USD 11.1 million in funding from the government of Canada to advance the mRNA vaccine technology. This funding aims to improve their efficacy, reduce the potential side effects of vaccines, and allow for a smaller vaccine dosage. Similarly, in December 2022, ExPLoRNA Therapeutics received USD 813,578 in funding from the Bill & Melinda Gates Foundation to further develop its mRNA technology. Therefore, rising funding for research is expected to increase the need for mRNA synthesis raw materials and fuel the market growth during the forecast period.

Additionally, the growing prevalence of chronic and infectious diseases is increasing the therapeutic application of mRNA technology. For instance, according to WHO, cancer is one of the leading causes of death worldwide, causing almost one in six deaths, while cardiovascular diseases lead to an estimated 17.9 million deaths each year. In addition, according to WHO, about 10 million people worldwide contracted tuberculosis in 2020 (1.1 million children, 5.6 million men, & 3.3 million women). Hence, scientists in industries and universities worldwide are finding novel and innovative ways to develop therapeutics using mRNA technology to prevent and treat disease. For instance, researchers at Penn Medicine are using the mRNA platform to create vaccines for several conditions such as cancer, treatment for food and environmental allergies, genetic diseases, and heart attack and stroke, among others.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global recombinant DNA technology market size was valued at USD 728.9 billion in 2023 and is projected to grow at a CAGR of 5.4% from 2024 to 2030.

• The global DNA diagnostics market size was estimated at USD 10.64 billion in 2023 and is projected to grow at a CAGR of 4.51% from 2024 to 2030.

Key mRNA Synthesis Raw Materials Company Insights

The market players operating in the mRNA synthesis raw materials market are adopting product approval to increase the reach of their products in the market and improve the availability of their products in diverse geographical areas, along with expansion as a strategy to enhance production/research activities. In addition, several market players are acquiring smaller players to strengthen their market position. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies.

Key mRNA Synthesis Raw Materials Companies:

The following are the leading companies in the mRNA synthesis raw materials market. These companies collectively hold the largest market share and dictate industry trends

F. Hoffmann-La Roche Ltd.

Jena Bioscience GmbH

Merck KGaA

Yeasen Biotechnology (Shanghai) Co., Ltd.

BOC Sciences

Thermo Fisher Scientific, Inc.

Maravai LifeSciences

New England Biolabs

Creative Biogene

HONGENE

Recent Developments

In April 2024, Telesis Bio Inc. announced its refocusing strategy to promote its innovative Gibson SOLA platform, targeting DNA and mRNA drug discovery. The company will also concentrate on enhancing its BioXp platform for mRNA synthesis, leveraging its distinct competitive advantage.

In February 2023, Life Edit Therapeutics Inc. and Moderna Inc. signed a collaboration agreement to discover and develop mRNA gene-editing therapies.

In January 2023, BioNTech and the UK Government signed a Strategic Partnership Agreement to help patients by advancing clinical trials for targeted mRNA immune therapies. To provide targeted cancer therapies to up to 10,000 patients by the end of 2030, through clinical trials or as approved treatments

Order a free sample PDF of the MRNA Synthesis Raw Materials Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Oligonucleotide Synthesis Market Analysis And Segment Forecast 2024-2030

The global oligonucleotide synthesis market size was estimated at USD 3.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. 

The decreasing prices of sequencing have led to increasing demand for custom-made nucleotides for applications across genetic testing, research, forensics applications, and drug development. This has further boosted the demand for oligonucleotide synthesis. The COVID-19 pandemic has affected every market globally and there has been a surge in the demand for efficient treatment against COVID-19.

Gather more insights about the market drivers, restrains and growth of the Oligonucleotide Synthesis Market

Oligonucleotide therapeutics hold immense potential for treating chronic conditions such as cardiovascular diseases, cancers, and retinal disorders. Emerging new applications of oligo sequences in multiple fields of biotechnology are expected to increase market growth. Demand for molecular diagnostics in precision care is an important emerging application field for oligonucleotide synthesis.

The introduction of advanced techniques such as CRISPR and high-throughput sequencing for gene expression analysis has simplified the genetic screening and modification of genomes. Such innovations are observed to influence the demand for oligonucleotide synthesis. Manufacturers invest in technology development to enable the production of long Oligonucleotides with higher precision and better yield to cater to the growing need for custom oligos.

The availability of a regulatory environment that supports the progress of genomics is the key factor contributing to the market growth. Changes in the regulatory policies to provide a well-framed environment for advanced biological research and application in human use are expected to influence demand for oligonucleotide synthesis significantly. Stem cells, regenerative medicine, genetic engineering, and synthetic biology are the prominent fields identified with high potential in healthcare. For instance, the International Society for Stem Cell Research (ISSCR) ethics and public policy committee aims to recognize and resolve issues by conducting open discussions. The committee includes experts in ethics, law, and social policy worldwide.

Oligonucleotide Synthesis Market Segmentation

Grand View Research has segmented the global oligonucleotide synthesis market report based on product & service, application, and region:

Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

• Oligonucleotides

o DNA

o Column-based

o Array-based

o RNA

o By Technology

o Column-based

o Array-based

o By Type

o Short RNA Oligos (<65 nt)

o Long RNA Oligos (>65 nt)

o CRISPR (sgRNA)

• Equipment/Synthesizer

• Reagents

• Services

o DNA

o Custom Oligo Synthesis Services

o 25 nmol

o 50 nmol

o 200 nmol

o 1000 nmol

o 10000 nmol

o Modification Services

o Purification Services

o RNA

o Custom Oligo Synthesis Services

o 25 nmol

o 100 nmol

o 1000 nmol

o 10000 nmol

o Modification Services

o Purification Services

Application Outlook (Revenue, USD Million, 2018 - 2030)

• PCR Primers

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• PCR Assays & Panels

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• Sequencing

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• DNA Microarrays

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• Fluorescence In Situ Hybridization (FISH)

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• Antisense Oligonucleotides

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• Other Applications

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Spain

o Italy

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

• The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Some of the key players operating in the market include Merck KGaA, Thermo Fisher Scientific, Inc., and Agilent Technologies. These players focus on business strategies such as partnerships/collaborations, product launches, and expansion. Twist Bioscience, Biolegio, and LGC Biosearch Technologies are some of the emerging market participants in the oligonucleotide market. These players primarily focus on expansion and partnerships to strengthen their position in the market.

Key Oligonucleotide Synthesis Companies:

• Thermo Fisher Scientific, Inc.

• Merck KGaA

• Danaher Corporation

• Dharmacon Inc.

• Agilent Technologies

• Bio-synthesis

• Kaneka Eurogentec S.A

• LGC Biosearch Technologies

• Biolegio

• Twist Bioscience

Recent Developments

• In October 2023, IDT inaugurated a new therapeutic manufacturing facility to meet the increasing demand in genomic medicine. The new facility is equipped to support the production of therapeutic oligonucleotides, catering to the expanding needs in the field of genomics and personalized medicine.

• In September 2023, Danaher Corporation (Integrated DNA Technologies) introduced a range of xGen NGS products tailored for the Ultima Genomics UG 100TM platform. The suite includes adapters, primers, and universal blockers, catering to various applications such as DNA, RNA, & methylation sequencing workflows. This offering is complemented by IDT's proven hybridization capture chemistry, enhancing versatility for researchers.

• In July 2023, Analytix introduced two new instruments designed for organic synthesis, including wavePREP, tailored for oligonucleotide synthesis, and Xelsius, a workstation for multireaction synthesis.

• In May 2023, GenScript expanded its life sciences facility in Zhenjiang, Jiangsu, China, to offer a rapid, high-purity oligonucleotide and peptide synthesis service tailored for research & development as well as preclinical applications.

• In May 2023, Twist Bioscience and CeGaT GmbH launched the Twist Alliance CeGaT RNA Fusion Panel. This collaborative effort aims to provide a specialized tool for oncology research, facilitating the detection of RNA fusions and enabling transcript variant analysis. RNA fusions, a result of chromosomal arrangements often seen in cancers, can now be efficiently studied using this newly introduced panel.

• In February 2023, Fluor Corp. and Agilent Technologies, Inc. collaborated to enhance its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. Under this collaboration, Fluor is expected to support the project's engineering and procurement. The total value of the project is evaluated at USD 725 million.

Order a free sample PDF of the Oligonucleotide Synthesis Market Intelligence Study, published by Grand View Research.

[soumyafwr]

DNA Synthesis Market Overview, Size, Share and Forecast 2031

[ps1396262]

DNA Data Storage Market Size, Revenue Analysis, Opportunities, Trends, Product Launch, 2024–2030

The DNA Data Storage Market was valued at USD 357 million in 2023-e and will surpass USD 3,100 million by 2030; growing at a CAGR of 89.3% during 2024 - 2030. one of the most fascinating and promising technologies on the horizon is DNA data storage. Imagine storing the entire contents of the Library of Congress in a space no bigger than a sugar cube.

This is not science fiction; it’s the potential of DNA data storage. As the volume of digital data continues to explode, traditional storage mediums like magnetic tapes and hard drives are struggling to keep up. Enter DNA, the blueprint of life, which offers a revolutionary way to store vast amounts of information in an incredibly compact form.

Get a Sample Report: https://intentmarketresearch.com/request-sample/dna-data-storage-market-3588.html

What is DNA Data Storage?

DNA data storage refers to the process of encoding binary data (the 1s and 0s that make up digital files) into the four-letter nucleotide code of DNA (A, T, C, G). This is done by converting binary data into a sequence of DNA nucleotides, which are then synthesized into actual DNA molecules. These molecules can be read back and decoded into the original binary data, making DNA an incredibly dense and durable medium for storing digital information.

Why DNA?

DNA has several unique properties that make it an attractive option for data storage:

Density: DNA is incredibly dense; a single gram of DNA can theoretically store up to 215 petabytes (215 million gigabytes) of data.

Longevity: Unlike traditional storage mediums that degrade over time, DNA can remain stable for thousands of years under the right conditions, ensuring long-term data preservation.

Sustainability: With the growing environmental concerns surrounding data centers and their energy consumption, DNA offers a sustainable alternative, as it requires no power for storage.

The Growing Market for DNA Data Storage

The potential of DNA data storage is attracting significant interest from various industries, including technology, healthcare, and finance. As the demand for data storage continues to surge, companies are exploring DNA as a long-term solution to meet the world’s growing data needs.

Market Trends

Rising Data Generation: The exponential increase in data generation, driven by the Internet of Things (IoT), big data analytics, and artificial intelligence, is one of the primary drivers of the DNA data storage market.

Investment in Research and Development: Companies and research institutions are investing heavily in R&D to overcome the current challenges of DNA data storage, such as the high cost of DNA synthesis and sequencing. Advances in these areas are crucial for making DNA data storage commercially viable.

Collaborations and Partnerships: There has been a rise in collaborations between tech giants, biotech companies, and academic institutions aimed at accelerating the development and commercialization of DNA data storage technology.

Government Initiatives: Governments worldwide are recognizing the strategic importance of advanced data storage technologies and are supporting research initiatives that focus on DNA data storage.

Challenges to Overcome

Despite its enormous potential, DNA data storage faces several challenges that must be addressed before it can become a mainstream technology:

Cost: Currently, the cost of synthesizing and sequencing DNA is prohibitively high. However, as technology advances, these costs are expected to decrease significantly.

Speed: Writing and reading data in DNA is slower than in traditional storage systems. Improving the speed of data retrieval and encoding is a critical area of research.

Error Rates: DNA synthesis and sequencing processes can introduce errors. Developing more accurate and reliable methods is essential for the technology’s success.

Get an insights of Customization: https://intentmarketresearch.com/ask-for-customization/dna-data-storage-market-3588.html

The Road Ahead

The DNA data storage market is still in its infancy, but its future is bright. As technological barriers are overcome, DNA has the potential to revolutionize the way we think about data storage. In the next decade, we can expect to see significant advancements in this field, with DNA storage emerging as a viable solution for archiving vast amounts of data.

The integration of DNA data storage into mainstream technology will likely occur gradually, starting with applications where long-term data preservation is critical, such as in historical archives, government records, and large-scale data centers. As the technology matures, it could eventually become a standard for data storage, offering an efficient, sustainable, and durable solution for the digital age.

Conclusion

The DNA data storage market represents a fascinating intersection of biology and technology, with the potential to transform the future of information storage. As we continue to generate data at an unprecedented rate, DNA may provide the key to unlocking a new era of data management, one where the limits of current storage technologies are surpassed, and the full potential of our digital world is realized.

[poonamcmi]

Oligonucleotide Synthesis Market is Expected to Witness High Growth Owing to Rising Biotechnology Research and Development

The oligonucleotide synthesis market involves the production of shorter sequences of nucleic acids known as oligonucleotides that are widely used in research, diagnostics and therapeutics applications. Oligonucleotides play a vital role in gene expression studies, next-generation sequencing, DNA & RNA analysis, qPCR and molecular diagnostics. The increasing focus on biotechnology research especially in life sciences and genomics has boosted the demand for specialized oligonucleotides.

The Global oligonucleotide synthesis market is estimated to be valued at US$ 4565 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period of 2024 to 2031.

Key Takeaways Key players operating in the oligonucleotide synthesis are Forte Research Systems (India), ICON plc (Ireland), Merge healthcare incorporated (U.S.), Bio-Optronics (U.S.), DSG INC (U.S.), ArisGlobal (India), ERT Clinical Bioclinica (U.S.), Oracle Corporation (U.S.), Medidata Solutions (U.S.), DATATRAK International, Inc. (U.S.), and MedNet Solutions, Inc., (U.S.) among others. These key players are focusing on partnerships and new technology development to expand their oligonucleotide synthesis capabilities.

Key Oligonucleotide Synthesis Market Demand include increasing research in personalized medicine and precision genomics. Additionally, the growing pipeline of oligo-based drugs and clinical trials for rare diseases will provide momentum.

With regards to geographical expansion, North America dominates the global oligonucleotide synthesis market followed by Europe. However, Asia Pacific is expected to witness highest growth rate owing to increasing government support for biotech sector and growing industry investments in China and India.

Market Drivers Increasing R&D expenditure for biotechnology research especially in life sciences and biopharmaceutical industry is a key factor contributing to the Oligonucleotide Synthesis Market Size And Trends Oligonucleotides play a vital role in new drug discovery and development which is propelling many biotech companies to adopt oligo synthesis. Rising applications of oligos in development of advanced therapeutics like antisense oligonucleotides and siRNA is expected to drive the market during the forecast period.

PEST Analysis Political: Government regulations around drug research and development have an impact. Changes in healthcare policies and funding also affect the market. Economic: The state of the economy influences research spending by pharmaceutical companies and academic institutions, affecting demand. Rising healthcare costs drive need for new drug therapies. Social: An aging global population with increased prevalence of diseases like cancer is leading to higher demand for advanced drug development and diagnostic tools. Social attitudes around health and biotech also evolve over time.

Technological: Advancements in DNA sequencing, synthesis and analysis technologies enable new applications and drive down costs, expanding the potential market. Automation and artificial intelligence are enhancing R&D productivity.

North America holds the largest share in terms of value currently due to heavy spending on drug R&D by major players in the US and Canada. However, Asia Pacific is expected to grow at the fastest rate during the forecast period as the pharmaceutical industry expands rapidly in major emerging economies like China and India. These countries are making large investments in research and increasing regulatory approvals are also supporting market growth.

Europe accounts for a sizable share as well owing to extensive government funding for research programs. However, the high costs of oligonucleotide therapies has limited their use thus far. If pricing and reimbursement improve in the future, the European market could witness stronger growth. On the other hand, the Middle East and Africa region is relatively nascent but demand may rise over time with economic development across various nations. Get More Insights On, Oligonucleotide Synthesis Market About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, c